Anti-p53 antibodies are among the most studied, and a large systematic review clearly highlighted the correlation between p53-specific autologous antibodies and decreased overall, and progression-free, survival in breast, lung, colon, and oral cancer [44]. Here, TP53 is linked to lip and oral cavity carcinoma.